BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1976775)

  • 1. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
    Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
    J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the rat during chronic dapsone administration.
    Coleman MD; Tingle MD; Park BK
    J Pharm Pharmacol; 1991 Mar; 43(3):186-90. PubMed ID: 1675276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
    Coleman MD; Russell RM; Tingle MD; Park BK
    J Pharm Pharmacol; 1992 Feb; 44(2):114-8. PubMed ID: 1352810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of H(2)-receptor antagonists on dapsone-induced methaemoglobinaemia in rats.
    Malfará WR; Pereira CP; Santos AC; Queiroz RH
    Pharmacol Res; 2002 Apr; 45(4):269-73. PubMed ID: 12030789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
    Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK
    J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
    Coleman MD; Scott AK; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
    Ahmadi M; Khalaf LF; Smith HJ; Nicholls PJ
    J Pharm Pharmacol; 1996 Feb; 48(2):228-32. PubMed ID: 8935178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
    Coleman MD; Rhodes LE; Scott AK; Verbov JL; Friedmann PS; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1992 Sep; 34(3):244-9. PubMed ID: 1389948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
    Irshaid Y; Adedoyin A; Lotze M; Branch RA
    Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat.
    Coleman MD; Tingle MD; Winn MJ; Park BK
    J Pharm Pharmacol; 1990 Oct; 42(10):698-703. PubMed ID: 1982141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
    Pochopin NL; Charman WN; Stella VJ
    Drug Metab Dispos; 1994; 22(5):770-5. PubMed ID: 7835230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dapsone-induced methaemoglobinaemia in the rat.
    Coleman MD; Winn MJ; Breckenridge AM; Park BK
    Biochem Pharmacol; 1990 Feb; 39(4):802-5. PubMed ID: 2306285
    [No Abstract]   [Full Text] [Related]  

  • 13. The disposition of dapsone and monoacetyldapsone in the dog (38516).
    Peters JH; Gordon R; Biggs JT; Levy L
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):251-5. PubMed ID: 1129265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of dapsone and acetylated dapsone in serum and saliva.
    Lammintausta K; Kangas L; Lammintausta R
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):159-63. PubMed ID: 447435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.
    Vage C; Saab N; Woster PM; Svensson CK
    Toxicol Appl Pharmacol; 1994 Dec; 129(2):309-16. PubMed ID: 7992320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of K-C1 cotransport in rat red cells by a hemolytic anemia-producing metabolite of dapsone.
    Haas M; Harrison JH
    Am J Physiol; 1989 Feb; 256(2 Pt 1):C265-72. PubMed ID: 2919657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone hydroxylamine inhibits the LTB4-induced chemotaxis of polymorphonuclear leukocytes into human skin: results of a pilot study.
    Wozel G; Blasum C; Winter C; Gerlach B
    Inflamm Res; 1997 Oct; 46(10):420-2. PubMed ID: 9372316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute dapsone intoxication: a case with prolonged symptoms.
    Elonen E; Neuvonen PJ; Halmekoski J; Mattila MJ
    Clin Toxicol; 1979; 14(1):79-85. PubMed ID: 436385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of proguanil on the pharmacokinetics of dapsone in healthy volunteers.
    Edstein MD; Rieckmann KH
    Chemotherapy; 1993; 39(4):235-41. PubMed ID: 8325124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.